ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.4050
-0.0450 (-10.00%)
Mar 3, 2026, 3:53 PM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 21.89 million as of March 4, 2026. Its market cap has decreased by -3.86% in one year.
Market Cap
21.89M
Enterprise Value
19.16M
Revenue
29.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 21.89M, a decrease of -12.41%. That is a compound annual growth rate of -1.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 21.89M | 1.25% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mach7 Technologies | 76.38M |
| Beamtree Holdings | 45.05M |
| Emyria | 41.13M |
| Vitasora Health | 40.88M |
| PainChek | 34.49M |
| TrivarX | 28.84M |
| Resonance Health | 18.04M |
| Pathkey.AI | 16.39M |